Back

Cardiovascular outcomes in patients with newly diagnosed atrial fibrillation and previous stroke: a plausible impact of stroke-heart syndrome using longitudinal data from the GLORIA-AF registry

31 August 2024 (18:00 - 18:40)
Organised by: Logo
Congress Presentation Part of: Epidemiology of stroke in patients with heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Steven Ho Man Lam

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Echocardiographic signs of atrial cardiopathy and MRI-detected silent brain infarcts in a middle-aged cohort: the Akershus Cardiac Examination 1950 Study
Mr H. Ihle-Hansen (Gjettum, NO)
Abstract Slides Video
Presentation thumbnail
High ABCD2-score after transient ischemic attack is associated with a two-fold higher stroke-rate during long-term follow-up
Miss K. Al-Chaer (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Predictors of Ischemic Stroke in a cohort of patients with Chagas Cardiomyopathy: the CLOT-Chagas study
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides
Presentation thumbnail
The very long-term risk of stroke after acute coronary syndrome and geographic differences. The ABC-10* study on heart disease.
Doctor G. Berton (Conegliano, IT)
Abstract Slides Video
Presentation thumbnail
Left atrial cardiomyopathy predicts stroke recurrence and atrial fibrillation
Ms L. Friderichsen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology of stroke in patients with heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET
You may be interested in
thumbnail
Congress Session
Registries, observational, and other studies on atrial fibrillation
thumbnail
Congress Session
Stroke prediction in atrial fibrillation
thumbnail
Congress Session
Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources